Search

Displaying results 7611 - 7620 of 10000 in total
  1. Drug

    Ricolinostat

    go.drugbank.com/drugs/DB12376
    Investigational

    Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.

  2. Drug

    Esreboxetine

    go.drugbank.com/drugs/DB12395
    Investigational

    Esreboxetine has been used in trials studying the treatment and basic science of Fibromyalgia.

  3. Drug

    Lifibrol

    go.drugbank.com/drugs/DB12448
    Investigational

    Lifibrol has been used in trials studying the basic science of Hyperlipoproteinemia and Hypercholesterolemia.

  4. Drug

    GLB-007

    go.drugbank.com/drugs/DB32798
    Experimental

    GLB-007 is a molecular glue degrader targeting WIZ and ZBTB7A.[L56125, L56126, L56128]

  5. Drug

    NM3086

    go.drugbank.com/drugs/DB17719
    Experimental

    NM3086 is a recombinant, humanized, aglycosylated, IgG1-kappa anti-properdin monoclonal antibody being developed by Novelmed Therapeutics Inc.[L46193]

  6. Drug

    PF-05089771

    go.drugbank.com/drugs/DB14856
    Investigational

    PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).

  7. Drug

    Dalfampridine

    go.drugbank.com/drugs/DB06637
    ApprovedInvestigational

    Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.

  8. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

    Categories: Nucleic Acids, Nucleotides, and Nucleosides
  9. Drug

    Carbomer

    go.drugbank.com/drugs/DB15649
    Investigational

    Mixtures: RUNYI MIAOJIE Hand sanitizer, RUNYI MIAOJIE Hand sanitizer
  10. Drug

    MC-1

    go.drugbank.com/drugs/DB05315
    Experimental

    Medicure's MC-1 drug is a cardio-protectant, designed to reduce the damage to the heart when arteries are blocked and when they are subsequently reopened after bypass surgery.